FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2

• Published in: Pharmaceuticals (Basel, Switzerland) Vol. 13; no. 12; p. 443
• Main Authors: Mostafa, Ahmed, Kandeil, Ahmed, A. M. M. Elshaier, Yaseen, Kutkat, Omnia, Moatasim, Yassmin, Rashad, Adel A., Shehata, Mahmoud, Gomaa, Mokhtar R., Mahrous, Noura, Mahmoud, Sara H., GabAllah, Mohamed, Abbas, Hisham, Taweel, Ahmed El, Kayed, Ahmed E., Kamel, Mina Nabil, Sayes, Mohamed El, Mahmoud, Dina B., El-Shesheny, Rabeh, Kayali, Ghazi, Ali, Mohamed A.
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI 04.12.2020; MDPI AG
• Subjects: antiviral; COVID-19; drug repurposing; SARS-CoV-2; virtual screening; COVID-19; SARS-CoV-2; drug repurposing; virtual screening; antiviral

(1) Background: Drug repositioning is an unconventional drug discovery approach to explore new therapeutic benefits of existing drugs. Currently, it emerges as a rapid avenue to alleviate the COVID-19 pandemic disease. (2) Methods: Herein, we tested the antiviral activity of anti-microbial and anti-...